Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Context Therapeutics Inc CNTX

Healthcare
Context Therapeutics Inc. is a biopharmaceutical company advancing medicines for solid tumors. The Company is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, which is in preclinical development. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarian, endometrial, testicular, and lung, and... see more

Bullboard (NDAQ:CNTX)

View:
Comment by Iseneschalon Feb 02, 2023 11:59am

RE:CNTX...... mini pop to $1.15

SILO....... pop....now $3.65 Shoulda coulda
63
Discussion
Post by Iseneschalon Jan 31, 2023 3:42pm

CNTX...... mini pop to $1.15

I like to leave some for the next guy ; )  Cheers............oh....take a look at SILO on NASDAQ...share buyback! $2.75 u.s
79
Discussion
Post by Iseneschalon Jan 31, 2023 3:22pm

CNTX ....still climbing the RBL

$1.10 Me ...no position ; )
64
Post by Iseneschalon Jan 31, 2023 10:48am

CNTX ....outside chance here at $1.15 for a bounce

Was in PB mode ....has since switched to "sideways" mode Range bound....check ur charts in the 5 min
41
Post by Iseneschalon Jan 31, 2023 10:17am

CNTX ....early am runner in PB mode

You'd be a spearcatcher now Done
53
Post by Shanemorg58on Jan 06, 2023 11:10am

Strong Hold!

https://www.edisongroup.com/publication/a-catalyst-rich-period-ahead/31836/ the company is making really good progress in advancing both of its pipeline assets, and not to mention presenting ...more  
51
Post by Shanemorg58on May 13, 2022 9:23am

Awesome webinar!

https://twitter.com/Context_Tx/status/1525083585610383360 Check out this awesome R&D Webinar! Big things coming for CNTX!
53
Post by Shanemorg58on May 05, 2022 10:02am

Huge potential

https://www.biospace.com/article/context-therapeutics-is-targeting-progesterone-to-outsmart-tumors-in-women-s-cancers-/ wow Context therapeutics is targeting progesterone receptors to help ensure ...more  
48
Post by Shanemorg58on Apr 22, 2022 10:26am

Strong Hold!

https://www.americanbankingnews.com/2022/04/22/context-therapeutics-nasdaqcntx-stock-rating-upgraded-by-zacks-investment-research.html Upgraded to a strong hold! LFGG!
65
Post by Iseneschalon Dec 10, 2021 12:04pm

CNTX ..... What an implosion !!!!!

I knew it ....didn't like it from the start !!
74
Post by Iseneschalon Dec 10, 2021 8:37am

CNTX ....early a.m runner on NR

Make note: IPO'd last Oct at $5........ the a P.P at $6.25 Dec 01 Trade accordingly  Cheers !
94
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities